Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Residual Lesions”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableLooking for participantsNCT07006012
What this trial is testing

RGL-305+ Lymphoma + Exploratory Clinical Study

Who this might be right for
Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University 12
Not applicableUnknownNCT05310357
What this trial is testing

Chromosomal Instability in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerHigh-grade Serous Ovarian CarcinomaChromosomal Instability+5 more
Lei Li 300
Early research (Phase 1)Looking for participantsNCT05240950
What this trial is testing

Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases

Who this might be right for
Colorectal CancerMetastatic Liver Cancer
Changhai Hospital 18